SEC Info - Immunomedics Inc. - ‘SC14D9C’ on 9/14/20 re: Immunomedics Inc.

SEC Info℠

Home

Help

Please Sign In

Immunomedics Inc. – ‘SC14D9C’ on 9/14/20 re: Immunomedics Inc.

On: Monday, 9/14/20, at 5:14pm ET · Accession #: 1104659-20-104908 · File #: 5-35857

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/14/20  Immunomedics Inc.                 SC14D9C                2:26K  Immunomedics Inc.                 Toppan Merrill/FA

Tender-Offer Communication by an Issuer re: a Third-Party Offer — Sch. 14D-9C
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC14D9C     Tender-Offer Communication by an Issuer re: a       HTML      8K 
                Third-Party Offer                                                
 2: EX-99.1     Miscellaneous Exhibit                               HTML     17K

‘SC14D9C’ — Tender-Offer Communication by an Issuer re: a Third-Party Offer

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14D-9

(Rule 14d-101)

SOLICITATION/RECOMMENDATION STATEMENT

UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934

IMMUNOMEDICS, INC.

(Name of Subject Company)

IMMUNOMEDICS, INC.

(Name of Person Filing Statement)

COMMON STOCK, PAR VALUE $0.01 PER SHARE

(Title of Class of Securities)

452907108

(CUSIP Number of Class of Securities)

Usama Malik
Chief Financial Officer, Chief Business Officer
Immunomedics, Inc.
300 The American Road

Morris Plains, New Jersey 07950
(973) 605-8200

(Name, address and telephone numbers of person authorized to receive notices and communications

on behalf of the persons filing statement)

With copies to:

Adam O. Emmerich
Victor Goldfeld
Wachtell, Lipton, Rosen & Katz
51 West 52nd Street
New York, New York 10019
(212) 403-1000

Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

The information set forth under Items 1.01, 8.01 and 9.01 of the Current Report on Form 8-K filed by Immunomedics, Inc. (the “Company”) on September 14, 2020 (including all exhibits attached thereto) is incorporated herein by reference.

Announcement to employees (Exhibit 99.1)

Dates Referenced Herein and Documents Incorporated by Reference

This ‘SC14D9C’ Filing	Date	Other Filings

Filed on:	9/14/20	4, 8-K, SC TO-C
		List all Filings

1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/14/20  Immunomedics Inc.                 8-K:1,8,9   9/13/20   12:926K                                   Toppan Merrill/FA

↑Top

Filing Submission 0001104659-20-104908 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)